Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413862
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-05-07
Brief Title:
Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy
Sponsor:
Baoding First Central Hospital
Organization:
Baoding First Central Hospital
Study Overview
Official Title:
Efficacy and Safety of Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ciprofol exhibits comparable efficacy to that of propofol and is associated with less injection pain rate fewer adverse events higher patient satisfaction and more stable hemodynamics when used for general anesthesia during the painless hysteroscopy
Detailed Description:
In this study we found that sedation success rate was 100 in both ciprofol group and propofol group during the painless hysteroscopy The incidence rate of injection pain and the intensity of pain in the ciprofol group were significantly lower than the propofol group Also the ciprofol group had lower incidence rate and severity level of adverse events and higher patient satisfaction In addition SBP DBP and MAP values in propofol group were found to be significantly lower than those in ciprofol group at the time of cervical dilation and of consciousness recovery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None